Your browser doesn't support javascript.
loading
Controlling Conjugated Antibodies at the Molecular Level for Active Targeting Nanoparticles toward HER2-Positive Cancer Cells.
Li, Mingyang; Dong, Jicheng; Cheng, Fang; Li, Chunmei; Wang, Huanan; Sun, Tao; He, Wei; Wang, Qing.
Afiliação
  • Li M; State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Dong J; Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Cheng F; State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Li C; Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Wang H; State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Sun T; Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • He W; State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Wang Q; Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China.
Mol Pharm ; 18(3): 1196-1207, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33448219
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Nanopartículas / Anticorpos Limite: Female / Humans Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Nanopartículas / Anticorpos Limite: Female / Humans Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China